Patient Satisfaction Survey (PSS) In Breast Clinic (PSS)

• ClinicalTrials.gov Identifier: NCT03962595
• Recruitment Status: Unknown
• First Posted: May 24, 2019
• Last Update Posted: May 24, 2019
• Sponsor: Tata Memorial Centre
• Information provided by (Responsible Party): Dr. Tabassum Wadasadawala, Tata Memorial Centre

Study Description

Brief Summary:

Patient satisfaction is the primary means of assessing the effectiveness of primary health care delivery. It helps in improving the quality of care by identifying and help resolving the potential problem areas. It assesses the effectiveness of the care provided and document the quality to accrediting organisations.In our institute, we have developed a patient satisfaction survey (PSS) questionnaire and have conducted a pilot study (Institutional review board approved) with fifty English speaking breast cancer patients receiving active cancer directed treatment in outpatient clinic, to evaluate the level of patient satisfaction in them. Therefore, we are now conducting a linguistic validation study using Hindi and Marathi PSS questionnaire to assess the overall level of patient satisfaction in a larger cohort of patients with diverse linguistic and economic background attending both general and private Outpatient Clinic.

The aim of the study is to evaluate the overall level of patient satisfaction and their satisfaction at various encounters in the multi-disciplinary Breast Clinic which can be helpful to improve various aspects of patient care delivery.

Methods:

All patients who have already sort primary consultation in surgical, medical and radiation oncology outpatient clinics for their treatment plan and have had their last consultation within the last one month will be screened for the study. The Patient Satisfaction Survey (PSS) questionnaire (in preferred language) will be administered independently by a clinical research student who is not directly involved in patient care. The PSS will be anonymous. It will be administered to patients in the out-patient clinics waiting area. Patients will be asked to complete 3 surveys: one each for surgical, medical and radiation oncology professionals. It will take approximately 12 months to enroll the required number of patients.

Sample size: Previous studies conducted in India and the pilot study conducted at Tata Memorial Hospital (TMH) with the PSS questionnaire have shown that approximately 70% of the patients are satisfied with the health care services. Assuming that the proportion of patients satisfied with the health services, when assessed by Hindi and Marathi PSS questionnaire will be ± 5% of 70%, i.e. between 65% to 75%, a sample size of 340 will be needed to produces a two-sided 95% confidence interval, which is determined by using Confidence Intervals Formula- Clopper-Pearson method.

Potential Impact of the Study

1. Knowledge of patient satisfaction in breast cancer patients belonging to diverse linguistic and socio-economic background will help in improving the quality of life of patients using appropriate resources and measures relevant to Indian context.
2. Awareness of patient dissatisfaction will help improve doctor patient relationship.
3. Awareness of patient dissatisfaction will help to identify problem areas and improve the care delivery.

Condition or disease
Breast Cancer

Study Design

• Study Type: Observational
• Estimated Enrollment: 340 participants
• Observational Model: Other
• Time Perspective: Prospective
• Official Title: Assessment Of Patient Satisfaction Of Outpatient Care In The Multi-Disciplinary Breast Clinic- Linguistic Validation Study
• Actual Study Start Date: March 23, 2017
• Estimated Primary Completion Date: December 31, 2019
• Estimated Study Completion Date: December 31, 2019

Groups and Cohorts

Outcome Measures

Primary Outcome Measures :

1. Linguistic validation of patient satisfaction survey (PSS) questionnaires in Hindi and Marathi. [ Time Frame: 1 Year ]

   Scoring: For each of the rated 25 items, a score of 1-5 will be assigned. This gives a maximum score of 125 and a minimum score of 25. A score of 75 or above indicates that patient is satisfied with the care provided.

   Construct validity for the instrument will be assessed using Pearson's correlation between the items and scales (It-Sc i.e. convergent validity) and between scales (Sc-Sc i.e. discriminant validity). The correlation coefficient should be >0.4 and <0.7 for these respectively.

   Internal consistency (scale reliability) of the multi item questionnaires will be tested by Cronbach alpha coefficient. The internal consistency should be 0.70 or higher when scales are used for group comparisons.

Secondary Outcome Measures :

1. Proportion of patients having mean overall satisfaction score <70 [ Time Frame: 1 Year ]
   The distribution of patients having low satisfaction score < 70 across surgical, medical and radiation oncology will be studied and the comments provided by patients will help understand the reasons related to low satisfaction.
2. To compare the level of overall patient satisfaction between paid and service patients: percentage of patients having overall score below 75 of the maximum 125 [ Time Frame: 1Year ]
   The comments provided by patients will help understand the reasons related to low satisfaction and the difference between the two classes of patients will be known from the percentage of patients having overall score below 70 of the maximum 125

Eligibility Criteria

• Ages Eligible for Study: 18 Years to 70 Years (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No
• Sampling Method: Non-Probability Sample

Study Population

Breast cancer patients attending both Private and General out-patient clinic for consultation will constitute the target population of the study.

Criteria

Inclusion Criteria:

1. Women with histological confirmation of breast cancer.
2. Planned to receive multi-disciplinary curative active cancer directed treatment.
3. Aware of their diagnosis and treatment plan.
4. Willingness to participate in study.
5. Patient able to read and comprehend Hindi and Marathi. -

Exclusion Criteria:

1. Eastern Cooperative Oncology Group 4
2. Unable to read and fill the questionnaire -

Contacts and Locations

Contacts

Contact: Dr. Tabassum Wadasadawala, MBBS,MD,DNB; 02227405079; twadasadawala@actrec.gov.in

Locations

India

Tata Memorial Centre; Recruiting

Mumbai, Maharashtra, India, 400012

Contact: Tabassum Wadasadawala, MBBS,MD,DNB 02227405078 twadasadawala@actrec.gov.in

Principal Investigator: Tabassum Wadasadawala, MBBS,MD,DNB

Sponsors and Collaborators

Tata Memorial Centre

Investigators

• Principal Investigator: Dr. Tabassum Wadasadawala, MBBS,MD,DNB; Associate Professor, Breast Services

More Information

Additional Information:

Sitzia J, Wood N. Patient satisfaction: A review of issues and concepts. Social Science and Medicine. 1997;45(12):1829-43. 

Mendoza Aldana J, Piechulek H, al-Sabir A. Client satisfaction and quality of health care in rural Bangladesh. Bulletin of the World Health Organization. 2001; 79:512-7. 

Sharma A, Kasar PK, Sharma R. Patient satisfaction about hospital services: a study from the outpatient department of tertiary care hospital, Jabalpur, Madhya Pradesh, India. National Journal of Community Medicine. 2014;5(2):199-203. 

Lis CG, Rodeghier M, Gupta D. Distribution and determinants of patient satisfaction in oncology: A review of the literature. Patient Preference and Adherence. 2009;(3):287- 

Landen CN, Younger NO, Collins Sharp B a., Underwood PB. Cancer patients' satisfaction with physicians: Princess Margaret hospital satisfaction with doctor questionnaire results. American Journal of Obstetrics and Gynecology. 2003 May;188(5):1177-9. 

Bergenmar M, Nyl&#233;n U, Lidbrink E, Bergh J, Brandberg Y. Improvements in patient satisfaction at an outpatient clinic for patients with breast cancer. Acta oncologica (Stockholm, Sweden). 2006 Jan;45(5):550-8. 

Brown RF, Hill C, Burant CJ, Siminoff L A. Satisfaction of early breast cancer patients with discussions during initial oncology consultations with a medical oncologist. Psycho-oncology. 2009 Jan;18(1):42-9. 

• Responsible Party: Dr. Tabassum Wadasadawala, Associate Professor, Radiation Oncology, Breast Services, Tata Memorial Centre
• ClinicalTrials.gov Identifier: NCT03962595
• Other Study ID Numbers: 1835
• First Posted: May 24, 2019
• Last Update Posted: May 24, 2019
• Last Verified: May 2019

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No